Global Mosquito Borne Infections Testing Market Insights Forecasts to 2033  

• The Global Mosquito Borne Infections Testing Market Size was Valued at USD 23.80 Billion in 2023
• The Market Size is Growing at a CAGR of 7.87% from 2023 to 2033
• The Worldwide Mosquito Borne Infections Testing Market Size is Expected to Reach USD 50.75 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Mosquito Borne Infections Testing Market Size is Anticipated to Exceed USD 50.75 Billion by 2033, Growing at a CAGR of 7.87% from 2023 to 2033.  

Market Overview

Diseases caused by bacteria, viruses, or parasites that infect mosquitoes and bloodsucking insects like ticks can infect humans are known as mosquito borne infections. Zika, west Nile, Japanese encephalitis, dengue, malaria, chikungunya, and yellow fever are among the most prevalent and newly discovered viral diseases transmitted by mosquitos. Diseases spread by mosquitoes can cause fever, headaches, aches and pains in the body, rashes, nausea, and swollen lymph nodes as symptoms. Testing for mosquito borne infections is done to identify the possibility that a person has a particular virus infection. Testing for mosquito borne diseases can identify the virus using a patient's blood or urine sample. Technological developments, increased demand, and regulatory backing are some factors driving the growth in the mosquito borne infections testing market. Market growth is mostly driven by rising consumer demand and awareness of mosquito-borne infection testing products and services.  

Report Coverage

This research report categorizes the mosquito borne infection testing market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the mosquito borne infections testing market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the mosquito borne infections testing market.

Driving Factors

Growing healthcare awareness and the increasing frequency of infectious diseases like dengue, zika, and malaria are the main factors driving the market for mosquito borne infections testing. The market has also grown as a result of growing investments made by pharmaceutical firms and nonprofit organizations in the creation of more affordable and efficient testing kits. The factors that are anticipated to drive market growth include the expansion of government initiatives aimed at preserving population health and the growing backing of global institutions like the World Health Organization.

Restraining Factors

The issues that restrict the market growth are the more expansive periods required for the creation of testing kits and the weak supply chain management in certain developing countries.  

Market Segmentation

The mosquito borne infections testing market share is classified into type and application.  

• The molecular diagnostics segment is estimated to hold the largest market revenue share through the projected period.

Based on the type, the mosquito borne infections testing market is classified into molecular diagnostics, microspot array diagnostics, and others. Among these, the molecular diagnostics segment is estimated to hold the largest market revenue share through the projected period. Molecular diagnostics have excellent sensitivity, accuracy, and capacity to identify certain diseases even at low dosages. Molecular diagnostic methods, such as Polymerase Chain Reaction (PCR), are frequently used to identify diseases spread by mosquitoes, including dengue, malaria, and Zika virus.   

• The hospital segment is anticipated to hold the largest market share through the forecast period.

Based on the application, the mosquito borne infections testing market is divided into hospital, clinic, academic & research centers, and others. Among these, the hospital segment is anticipated to hold the largest market share through the forecast period. Hospitals deal with a large number of diagnostic tests due to the large number of patients who need accurate and fast testing for diseases spread by mosquitoes, like dengue, malaria, zika, and chikungunya.    

Regional Segment Analysis of the Mosquito Borne Infections Testing Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the mosquito borne infections testing market over the predicted timeframe.

North America is anticipated to hold the largest share of the mosquito borne infections testing market over the predicted timeframe. North America is the market leader due to its sophisticated technological infrastructure, significant R&D spending, and rapid adoption of cutting-edge technologies. Due to their supportive regulatory frameworks and strong demand in several industries, the United States and Canada make significant contributions.   

Asia Pacific is expected to grow at the fastest CAGR growth of the mosquito borne infections testing market during the forecast period. Asia Pacific emerging market for mosquito borne infections testing is expected to grow at a quick pace due to its developing economy, increased use of technology, and rising level of industrialization. Due to their sizable consumer bases and substantial infrastructure and technological expenditures, China, Japan, and India are important markets.   

Europe is anticipated to hold a significant share of the mosquito borne infections testing market over the predicted timeframe. Europe is not far behind the United States, supported by favorable governmental regulations, strong industrial sectors, and rising consumer demand for particular products and services. The increasing market for testing for mosquito borne infections, is driven by stricter laws, more public awareness, and technical developments in this region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the mosquito borne infections testing market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• NovaTec Immundiagnostica GmbH
• InBios International Inc.
• Abnova Corporation
• Abbott
• Thermo Fisher Scientific Inc.
• CerTest BIOTEC
• F. Hoffmann-La Roche Ltd.
• OriGene Technologies Inc.
• Quest Diagnostics
• KAO CORPORATION
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2024, the first Innovative Mosquito Destruction Spray to be announced in Thailand, "ARS Mos Shooter," was officially launched, according to a statement from KAO CORPORATION & EARTH.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the mosquito borne infections testing market based on the below-mentioned segments: 

Global Mosquito Borne Infections Testing Market, By Type

• Molecular Diagnostics
• Microspot Array Diagnostics
• Others

Global Mosquito Borne Infections Testing Market, By Application

• Hospital
• Clinic
• Academic & Research Centers
• Others

Global Mosquito Borne Infections Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa